September 2011 - Class Action Blog Archive
Hairloss Medicine Propecia Linked to Sexual Dysfunction
Popular hairloss medication Propecia has been linked to sexual dysfunction in men, according to a recent study by George Washington University Professor Michael S. Irwig.
Yaz Blood Clot Risk Continues to Concern FDA
The FDA released a communication on Monday stating that it “remains concerned” about the potentially higher risk of venal thromboembolism (a type of blood clot) in women taking Yaz, Yasmin, and other fourth-generation birth control pills containing drospirenone.
Medtronic Forced to Recall Pump Over Battery Flaw
The U.S. Food and Drug Administration has announced that the newly recalled Medtronic SynchroMed II Implantable Infusion Pump has a battery flaw that could be deadly.
FDA to Change Bisphosphonate Labels to Reflect Risk of Long-Term Use
A U.S. Food and Drug Administration (FDA) advisory panel recommended on Friday that osteoporosis drugs called bisphosphonates should now come with new and revised labels indicating the length of time it is safe to take the drugs.
Vaginal Mesh Problems Lead FDA to Consider Stricter Mesh Regulations
As explained in an official document released recently, the U.S. Food and Drug Administration (FDA) is considering tightening regulations on the use of vaginal mesh surgical products, citing the alleged high risk of negative complications from the devices.
Second Flood Insurance Policy Reportedly Forced on Some Homeowners
According to numerous claims around the United States, some mortgage companies are forcing homeowners to purchase unnecessary or excessive flood insurance policies, even if their homes are already covered.
James Hardie Siding Issues Led to Failed Consumer Expectations, Says Suit
James Hardie, the giant siding and backerboard manufacturer, is facing mounting claims that their fiber cement exterior siding does not last as long as the company led consumers to believe, and that warranty claims are not handled appropriately.
Stop Using ShoulderFlex Massager, Says FDA
The U.S. Food and Drug Administration (FDA) has released a safety alert warning consumers not to use the ShoulderFlex Massager, citing risk of strangulation.